Sanders Morris Harris LLC Invitae Corp Transaction History

Sanders Morris Harris LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 13, 2023	BUY	$0.6 - $1.53 $7,536 - $19,216	12,560 New	12,560 $7,000
Q2 2023 Jul 10, 2023	BUY	$1.05 - $1.63 $13,188 - $20,472	12,560 New	12,560 $14,000
Q4 2022 Jan 12, 2023	SELL	$1.71 - $3.61 $3,420 - $7,220	-2,000 Reduced 13.74%	12,560 $0
Q2 2022 Jul 11, 2022	BUY	$2.13 - $9.01 $31,012 - $131,185	14,560 New	14,560 $37,000
Q3 2021 Oct 13, 2021	SELL	$24.31 - $33.6 $152,666 - $211,008	-6,280 Closed	0 $0

Q2 2021 Jul 13, 2021	BUY	$26.09 - $40.4 $163,845 - $253,712	6,280 New	6,280 $209,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Sanders Morris Harris LLC, based on Form 13F filings with the SEC.

Stay updated on Sanders Morris Harris LLC with notifications on news.